Kelun-Biotech`s Sacituzumab Tirumotecan Results at ASCO Symposium
13 Feb 2025 //
PR NEWSWIRE
Kelun-Biotech`s Tagitanlimab Approved For Recurrent NPC Treatment
23 Jan 2025 //
PR NEWSWIRE
Kelun-Biotech`s TROP2 ADC Approved in China for Advanced TNBC
27 Nov 2024 //
PR NEWSWIRE
Kelun-Biotech’s TROP2-ADC SKB264 NDA Accepted by NMPA
31 Oct 2024 //
PR NEWSWIRE